Addiction science is at an impasse. Rates of addiction remain high. Translational results from decades of research conducted within the dominant brain disease paradigm are shockingly meager. Meanwhile ...
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...